Given the data discussed thus far we predicted that the IPF lung would be enriched for CXCR4+ fibroblasts and that CXCL12 and CXCL14 would co-localize with these same fibroblasts. The gene discussed is CXCR4; the disease is idiopathic pulmonary fibrosis.